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Summary
Secondary breast angiosarcoma is a known but rare late side-eff ect of breast cancer radiotherapy. Here are four 
 patients reported, irradiated in University Hospital for Tumours due to breast cancer who developed secondary angiosar-
coma several years after irradiation. Two patients eventually died of angiosarcoma. Tumour has various appearances and 
might not be visible on mammography or ultrasound, regularly used in order to detect locoregional relapse of breast cancer 
timely. Surgery remains the primary therapeutic approach.
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ANGIOSARKOM DOJKE UZROKOVAN ZRAČENJEM- PRIKAZ 4 SLUČAJA
Sažetak
Sekundarni angiosarkom dojke poznata je rijetka kasna komplikacija zračenja dojke. Prikazane su 4 bolesnice u kojih 
se razvio sekundarni angiosarkom nekoliko godina po završetku zračenja. Dvije bolesnice umrle su od posljedica angiosar-
koma. Tumor je različitog izgleda i ne mora nužno biti vidljiv na mamografi ji ili ultrazvuku, pretragama koje se uglavnom 
koriste za rano otkrivanje lokoregionalnog recidiva raka dojke. Kirurški zahvat i dalje ostaje prvi terapijski izbor.
KLJUČNE RIJEČI: rak dojke, angiosarkom, sekundarni tumori
INTRODUCTION
Breast angiosarcoma is a rare, aggressive ma-
lignancy of vascular endothelium. Radiotherapy-
induced angiosarcoma is cutaneous in origin, aris-
ing from the dermis and subcutis of the irradiated 
skin and may involve the underlying breast tissue. 
It is usually multifocal and widely distributed 
within the RT (radiation therapy) fi eld (1) and 
presents mostly as reddish-purple patches with 
surrounding hematoma, plaques, erythematous 
nodules, lumps, skin dimpling or thickening. Ra-
rely, it is associated with distant metastases. Being 
predominantly skin/subcutaneous malignancy, it 
might not be visible on mammography or ultra-
sound. Mammography can show skin thickening 
or increased density but cannot reliably distin-
guish between healthy tissue and angiosarcoma. 
Ultrasonically it is usually seen as a hyperechogen-
ic mass, but in one series of 21 patients, it was re-
ported to be misdiagnosed in about one third (2).
The absolute risk of secondary angiosarcoma 
is estimated to be less than 0.5% and the median 
latency period is about 4-8 years (3). However, its 
incidence is expected to rise since breast-conserv-
ing surgery followed by radiotherapy has become 
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standard of care in patients with early-stage breast 
cancer and survival rates in this group of patients 
are rising. The most common salvage treatment 
performed is a simple mastectomy. Data on che-
motherapy and radiotherapy, both in (neo)adju-
vant and palliative sett ing are limited.
Here are presented 4 cases of breast angiosar-
coma diagnosed in patients that were previously 
irradiated after breast-conserving surgery.
RESULTS
Case 1
At the age of 73 patient underwent right 
breast-conserving surgery and axillary node clear-
ance for an ER and PR positive and Her2 negative 
15 mm grade I invasive lobular carcinoma. No 
evidence of a tumor was found in axillary lymph 
nodes (0/15). Surgery was followed by radiothera-
py and adjuvant hormonal therapy (letrozole) for 
fi ve years. The right breast was irradiated with 50 
Gy in 25 fractions 3D CRT (three- dimensional 
conformal radiotherapy). A year earlier she has 
had a left nephrectomy due to renal carcinoma, 
which was staged as pT3N0. The patient had reg-
ular follow up visits with mammography and 
breast ultrasound alternatively every six months.
Seven years after radiotherapy completion 
patient presented with an itching papule sized 
about 1 cm, surrounded with a hematoma and 
skin thickening on an area of about 2x 5 cm just 
below the right breast nipple. Cytology revealed 
malignant mesenchymal tumor. Chest X-ray and 
abdominal ultrasound showed no evidence of the 
disease and the patient was referred for radical 
mastectomy. Histology revealed high-grade an-
giosarcoma sized 7 cm and located subepidermal 
and in subcutaneous fat tissue. Immunohisto-
chemistry confi rmed tumor cells expressing CD 
31 and factor VII with weak expression of CD 34 
and C-myc. Surrounding tissue was CK7 positive. 
The closest margin measured 10mm.
Three months after surgery a large recur-
rence appeared, covering the whole right half of 
the thoracic wall and spreading to her left breast. 
The whole- body CT scan showed no evidence of 
metastases. A left radical mastectomy with exci-
sion of a tumor and a fl ap reconstruction was per-
formed. Histology revealed a 17x 12 cm angiosar-
coma. Tumour infi ltrated fat tissue, underlying 
muscle, and dermis. Left breast was free from a 
tumor.
Two months after surgery patients had large 
recurrence on her right chest wall (20x 15 cm) with 
erythema, induration, and multiple lumps up to 3 
cm. She complained of itching and occasional 
pain. No systemic antineoplastic treatment was 
administered. One month later, nine months after 
the fi rst sign of angiosarcoma, the patient died.
Case 2
At the age of 79, the patient was diagnosed 
with right breast cancer and underwent breast-
conserving surgery with axillary dissection. A 12 
mm, grade 2 ductal invasive carcinoma, ER + and 
PR +, Her2 neg was found. Axillary lymph nodes 
were negative, 0/10. Hormonal therapy with anas-
trozole for fi ve years was prescribed and her right 
breast was irradiated with 50Gy in 25 fractions of 
conventional radiotherapy. Regular follow up vis-
its took place every 6 months. The patient had 
mammographies, breast ultrasound, and 1 MRI, 
all fi ndings showed no evidence of the disease.
Seven years after completion of radiotherapy 
patients came with 3 livid plaques up to 2 cm and 
skin thickening of her right breast. A biopsy was 
performed which showed no evidence of angio-
sarcoma. MRI revealed skin thickenings, measur-
ing 2 and 1 cm. The patient underwent wide exci-
sion. Tumour within reticular dermis with infi ltra-
tion of subcutis was histologically found, 
composed of atypical mitotically active endothe-
lial cells forming vascular channels. Immunohis-
tochemistry confi rmed tumor cells expressing CD 
31. Tumour was completely removed.
Eleven months later MRI showed skin thick-
ening and several enhancing lesions within the 
breast parenchyma. An abdominal ultrasound 
suggested no evidence of metastatic spread. After 
FNA confi rmation of angiosarcoma, the patient 
had a radical mastectomy. Histology showed nod-
ules up to 11 cm with CD 31 expression.
Two months later a recurrent lesion was 
again excised and pathology confi rmed angiosar-
coma. After two months one more excision had to 
be done. According to histological result, the pa-
tient had several tumors up to 11 cm within der-
mis and subcutis which infi ltrated the underlying 
muscle. Immunohistochemically tumors stained 
positive for CD 31 and factor VII and negative on 
CK7 and CD 34.
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In just three months patient suff ered an ex-
tensive unresectable recurrence and succumbed 
two years after the initial angiosarcoma diagnosis.
Case 3
A 64- year old patient has had right breast-
conserving surgery with axillary node clearance 
due to a triple negative ductal invasive carcinoma 
grade III sized 7mm, Ki67 20%. Axillary lymph 
nodes contained no tumor (0/17). She received six 
cycles of AC chemotherapy and underwent right 
breast adjuvant irradiation with 50 Gy in 25 frac-
tions, followed by boost doses, 3x 3 Gy 3D CRT. 
She had regular follow up visits with laboratory 
check-ups and yearly alternating breast ultra-
sound/mammography examinations, showing no 
evidence of the disease.
Six years after radiotherapy she noticed a red 
area on her right breast. Ultrasound showed just 
skin thickening. A biopsy followed by wide exci-
sion was performed. Histology revealed grade III 
angiosarcoma, sized 3 cm + foci located in the der-
mis and subcutaneous fat tissue with free surgical 
margins. Immunohistochemistry confi rmed that 
the tumor cells expressed CD 31, collagen IV and 
laminin. Chest X-ray and abdominal ultrasound 
did not show any evidence of metastatic spread.
Six months after surgery patient is still tumor 
free.
Case 4
This patient was diagnosed with right breast 
cancer at the age of 55. Breast-conserving surgery 
and axillary dissection were performed and his-
tology revealed ductal invasive carcinoma grade I, 
sized 10 mm, ER and PR positive, Her2 negative, 
axilla 0/14. Conventional postoperative irradia-
tion of right breast was performed, the patient re-
ceived 50 Gy in 25 fractions, followed by a boost 
4x 2,5 Gy and started with hormonal therapy: 
tamoxifen switched to anastrozole two years later.
Three years after primary treatment patient 
complained of bone pain; X-ray showing osteo-
lytic lesion in her right tibia sized 55 mm, later ir-
radiated with 1x 8Gy. Anastrozole has been re-
placed with exemestane and clodronate adminis-
tration was initiated. The patient continued to 
have regular follow up visits with mammogra-
phies, breast ultrasounds, and bone scans, all of 
them being inconspicuous.
Eight years post-irradiation patient present-
ed with erythematous skin thickening on her right 
breast, sized about 5 cm. Biopsy revealed angio-
sarcoma with positive margins. Immunohisto-
chemically a tumor stained positive for CD 34, CD 
31 and factor VIII. A simple mastectomy followed, 
histology did not show any a residual tumor. CT 
scan of chest, abdomen, and pelvis showed no 
evidence of distal spread. Hormonal treatment 
was discontinued.
Four years later the patient is still without 
evidence of the disease, both primary breast, and 
angiosarcoma (except for the described osteolytic 
metastasis in right tibia) and she is not receiving 
any cancer-specifi c therapy.
DISCUSSION
Secondary angiosarcomas are a well known 
but infrequent complication of breast cancer radi-
ation treatment. All four patients had breast-con-
serving surgery followed by radiotherapy, 50 Gy 
in 25 fractions. Two younger patients additionally 
received a boost dose on tumor bed, one 3x 3 Gy 
and the other one 4x 2,5 Gy. Two patients were ir-
radiated with 3-D conformal technique and two 
with a 2-D conventional technique. All patients 
had right breast cancer with negative lymph 
nodes; therefore, in all patients only right breast 
was irradiated. The period between radiotherapy 
and occurrence of angiosarcoma was six, seven, 
seven and eight years. Adjuvant breast cancer ra-
diotherapy after breast-conserving surgery is an 
eff ective treatment resulting in signifi cant reduc-
tion of both local and systemic recurrence and bet-
ter cancer-specifi c and overall survival (4). How-
ever, according to contemporary data, adjuvant 
radiotherapy is no longer justifi ed in patients with 
pT1-2N0 HR+ tumors aged more than 70 years at 
the time of diagnosis and receiving hormonal 
therapy. Although rates of locoregional recur-
rence are lower with radiotherapy, it does not con-
tribute to overall or cancer-specifi c survival in that 
subgroup of patients (5). Therefore, two of these 
patients developing angiosarcoma, today would 
not meet criteria for adjuvant radiotherapy and 
would not be irradiated. Unfortunately, exactly 
they had an aggressive form of the disease and 
eventually died of it. Also, these two patients, al-
though without signifi cant comorbidity, were of 
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advanced age at the time angiosarcoma was diag-
nosed, namely 80 and 86, which might have af-
fected their course of the disease.
Three patients had hormone positive disease 
and were receiving only hormonal therapy as a 
systemic treatment, and one patient was given 
chemotherapy because of a triple negative dis-
ease. One patient had an oligometastatic breast 
cancer and was irradiated due to bone metastasis 
before angiosarcoma occurred. Nevertheless, the 
patient is still well and without any tumor symp-
toms. None of these four patients with angiosar-
coma developed distant metastases.
After being treated for breast cancer, all pa-
tients had regular mammographies and breast ul-
trasound examinations in order to discover possi-
ble locoregional relapse at its earliest stage. Since 
angiosarcoma is predominantly skin/subcutane-
ous lesion, it is not necessarily detectable with 
these methods, which was the case in all our pa-
tients (6). That stresses the importance of inspec-
tion and palpation of the breast/irradiated area at 
each follow-up visit.
After being diagnosed with angiosarcoma, 
two patients had a radical mastectomy, one had 
radical mastectomy upon angiosarcoma, and one 
had wide excision. According to some authors, 
possible excision of all irradiated skin and thorac-
ic wall soft tissue might be connected with the im-
proved survival of these patients (3). Experience 
with this subgroup of patients is diff erent: 2 pa-
tients after mastectomy died of angiosarcoma, but 
one patient is alive and with no evidence of the 
disease after mastectomy. The patient only having 
wide excision is without signs of the disease 6 
months later, albeit this follow up period is prob-
ably too short to draw any conclusion regarding 
such approach effi  cacy.
CONCLUSION
Secondary breast angiosarcoma can occur 
several years after completion of breast cancer ad-
juvant radiotherapy. Being predominantly skin 
and subcutaneous tissue located lesion, it is easily 
visible during regular follow up visits but its non-
specifi c appearance can sometimes delay the diag-
nosis. Both patients and clinicians should be vigi-
lant of any skin changes for its early detection. 
Surgical treatment still remains a standard ap-
proach, though with various outcomes.
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